← Back to Search

Cockroach Reduction Intervention for Childhood Asthma (ARCHS Trial)

N/A

Recruiting

Led By Felicia Rabito, PhD

Research Sponsored by Tulane University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 5 - 17 years with uncontrolled persistent asthma

Experiencing at least one of the following: one overnight hospitalization for asthma within the past six months OR two unscheduled clinic or emergency department visits for asthma within the last 12 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3, 6, 9, 12 months

Awards & highlights

ARCHS Trial Summary

This trial is testing a cockroach reduction intervention to improve patient-centered asthma outcomes.

Who is the study for?

The ARCHS trial is for children aged 5-17 in the Greater New Orleans area with uncontrolled persistent asthma and exposure to cockroaches. They must have had recent hospital visits or symptoms due to asthma, sleep at the target home most of the week, and speak English or Spanish. Kids can't join if they smoke, take beta-blockers, have certain heart diseases (except hypertension), other serious illnesses requiring daily meds, are on immunotherapy, or plan to move soon.Check my eligibility

What is being tested?

This study tests two ways to reduce cockroach allergens in homes of asthmatic kids: one group uses insecticidal bait while another follows a tailored approach. The goal is to see which method better improves asthma-related health outcomes like symptom days, control over asthma, healthcare use and overall quality of life over a year.See study design

What are the potential side effects?

Since this trial involves environmental interventions rather than medications, direct side effects from treatments are minimal. However, there may be indirect effects related to changes in household pest populations.

ARCHS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 5 and 17 years old with asthma that isn't well-controlled.

Select...

I've been hospitalized overnight for asthma recently or had emergency visits twice last year.

ARCHS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3, 6, 9, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3, 6, 9, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Level of Asthma control

Maximum number of symptom days in the previous two weeks

Number of participants with an asthma related hospitalization, unscheduled clinic or emergency room visit for asthma in the previous month

Secondary outcome measures

Asthma quality of life

Cockroach exposure

ARCHS Trial Design

2Treatment groups

Active Control

Group I: Comparator 1 (tailored approach)Active Control1 Intervention

Multi-component intervention tailored to the participant's allergic profile.

Group II: Comparator 2 (insecticidal bait)Active Control1 Intervention

Insecticidal bait for cockroach reduction.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER

550 Previous Clinical Trials

29,996,658 Total Patients Enrolled

Tulane UniversityLead Sponsor

115 Previous Clinical Trials

226,212 Total Patients Enrolled

Felicia Rabito, PhD4.146 ReviewsPrincipal Investigator - Tulane University School of Public Health and Tropical Medicine

Tulane University

5Patient Review

Dr. Rabito is truly impressive! His intelligence is unmatched, and he makes sure to spend quality time with each patient. Even if he runs late, he is always apologetic. I would gladly wait hours to see him again!

Media Library

Comparator 1 (tailored approach) Clinical Trial Eligibility Overview. Trial Name: NCT04331353 — N/A

Childhood Asthma Research Study Groups: Comparator 1 (tailored approach), Comparator 2 (insecticidal bait)

Childhood Asthma Clinical Trial 2023: Comparator 1 (tailored approach) Highlights & Side Effects. Trial Name: NCT04331353 — N/A

Comparator 1 (tailored approach) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04331353 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this clinical research?

"Qualified applicants must have asthma and be between the ages of 5 to 17. The trial is aiming to enroll 290 participants in total."

Answered by AI

Is this research endeavor accepting participants aged 40 or above?

"According to the requirements listed on this trial, potential participants must range between 5 and 17 years old. There are 121 studies available for younger individuals and 199 for people over 65."

Answered by AI

What is the cap on the number of participants in this experiment?

"Accurate, the details posted on clinicaltrials.gov affirms that this trial is currently accepting volunteers. This medical experiment was first published on November 15th 2021 and last modified on March 21st 2022. The study needs to recruit 290 individuals from 1 sites."

Answered by AI

Are there vacancies for participants in this trial?

"Per clinicaltrials.gov, this trial has been recruiting subjects since its launch on November 15th 2020 and is still open for enrolment as of March 21st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Allergen Reduction and Child Health Study (ARCHS)

Felicia Rabito 2020. "The Allergen Reduction and Child Health Study (ARCHS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04331353.